- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06036225
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing. (PREPARE)
PREhabilitation for Patients Awaiting a Liver Transplantation: The Development and Feasibility Testing of a Remote Multicomponent pREhabilitation Intervention: PREPARE
This is a study developing a prehabilitation intervention and then testing the acceptability and feasibility of the intervention.
Start date Aug 2022 for Focus groups and Feb 2023 Co-design workshops and feasibility study date pending
Study Overview
Detailed Description
This study is using focus groups and experience based co-design workshops to co-design a remote multicomponent prehabilitation intervention for patients awaiting liver transplantation.
Once the intervention is developed it will then be tested for acceptability and feasibility with the liver transplantation cohort in Belfast Northern Ireland.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Suzanne Lester, PhD
- Phone Number: 07825515905
- Email: slester01@qub.ac.uk
Study Contact Backup
- Name: Judy Bradly, Prof
- Email: judy.bradley@qub.ac.uk
Study Locations
-
-
-
Belfast, United Kingdom
- Recruiting
- Queen's University Belfast
-
Contact:
- Judy Bradley, Prof
- Email: judy.bradley@qub.ac.uk
-
Sub-Investigator:
- Suzanne Lester, PhD
-
Principal Investigator:
- Roger McCorry, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- on the transplant waiting list
- grade 3 below for encephalopathy
Exclusion Criteria:
- grade 4 above encephalopathy
- Known adverse reaction to exercise
- New stroke
- lacks capacity to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Receiving the prehabilitation intervention
All participants will receive the prehabilitation intervention.
|
Remote prehabilitation multi-component.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment
Time Frame: 6 months
|
It will be presented in percentage form and will be defined by
Min score 0% Max Score 100% Higher values indicate a higher recruitment rate. |
6 months
|
Adherence
Time Frame: 6 months
|
This will be recorded using percentage and will be defined by
Min score 0% Max Score 100% Higher values indicate a higher adherence rate. |
6 months
|
Retention
Time Frame: 6 months
|
This will be recorded using percentage and will be defined by
Min score 0% Max Score 100% Higher values indicate a higher retention rate. |
6 months
|
Acceptability
Time Frame: 6 months
|
This will be measured using an acceptability questionnaire. Min score 0% Max Score 100% Higher values indicate a higher acceptability. |
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frailty
Time Frame: 6 months
|
The Liver frailty index. This index will determine the degree of frailty patients present while awaiting liver transplantation. This scale determines if the patients are frail, pre-frail or robust. Min score 1 Max Score 7 Higher values indicate a higher degree of frailty. |
6 months
|
Physical function
Time Frame: 6 months
|
6 minute walk test. This will be recorded in meters covered in the 6 minute duration of the test. Min score 0 Max Score 1000 Higher values indicate better physical function. |
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Roger McCorry, Dr, Belfast HSCT
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 21081JB-AS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplant
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityNot yet recruitingLiver Metastases | Liver Transplant; Complications | Liver Cancer | Transplant | Transplant; Failure, Liver | Transplant; Complication, Rejection | Transplant Dysfunction
-
University Health Network, TorontoNot yet recruitingSolid Organ Transplant | Liver Transplant | Kidney Transplant | Heart Transplant
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)TerminatedLiver Transplant | Kidney TransplantUnited States
-
Astellas Pharma Europe Ltd.CompletedLiver Transplant | Kidney TransplantItaly, Spain, Belgium, Germany, Latvia, Canada, Korea, Republic of, Czechia, Austria, Finland, Belarus, Estonia, France, Hungary, Ireland, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Sweden, Switzerland, United...
-
Memorial Bahçelievler HospitalCompletedLiver Diseases | Liver Failure | Liver Cirrhosis | Liver Transplant; Complications | Liver Transplant Rejection | Organ Transplant Failure or Rejection | Liver Transplant FailureTurkey
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedLiver Transplant | Kidney TransplantUnited States, Singapore
-
National Taiwan University HospitalUnknownRenal Transplant | Liver TransplantTaiwan
-
Paragonix TechnologiesEnrolling by invitationLiver Diseases | Liver Transplant Disorder | Liver Dysfunction | Liver Transplant RejectionUnited States
-
PilloxaTerminatedLiver Transplant; Complications | Kidney Transplant; ComplicationsSweden
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation...CompletedLiver Transplant Recipient | Living Donor (of the Respective Liver Transplant Recipient)United States
Clinical Trials on Prehabilitation
-
Stanford UniversityRecruitingSurgery | Thoracic Diseases | Gastrointestinal Disease | Preoperative Care | Gynecologic Disease | Immune System and Related Disorders | Urological DiseaseUnited States
-
Istituto Ortopedico GaleazziMinistry of Health, ItalyRecruiting
-
Mount Sinai Hospital, CanadaUniversity Health Network, TorontoUnknownPhysical Activity | Surgery | Gastrointestinal Cancer | PrehabilitationCanada
-
Nova Scotia Health AuthorityDalhousie UniversityNot yet recruiting
-
University Health Network, TorontoRecruiting
-
University Hospital, ToulouseRecruitingAbdominal Aortic AneurysmFrance
-
McGill University Health Centre/Research Institute...Recruiting
-
Guy's and St Thomas' NHS Foundation TrustCompletedVascular SurgeryUnited Kingdom
-
Imperial College Healthcare NHS TrustCambridge University Hospitals NHS Foundation Trust; Mid and South Essex NHS...CompletedAortic Aneurysm, AbdominalUnited Kingdom
-
Chinese University of Hong KongCompleted